Chromosomal aberrations and cancer risk: Results of a cohort study from Central Europe

Paolo Boffetta, Olga Van Der Hel, Hannu Norppa, Eleonora Fabianova, Aleksandra Fucic, S. Gundy, Juozas Lazutka, Antonina Cebulska-Wasilewska, Daniela Puskailerova, Ariana Znaor, Zsolt Kelecsenyi, Juozas Kurtinaitis, Jadwiga Rachtan, Alessandra Forni, Roel Vermeulen, Stefano Bonassi

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

A high level of chromosomal aberrations in peripheral blood lymphocytes may be an early marker of cancer risk, but data on risk of specific cancers and types of chromosomal aberrations (chromosome type and chromatid type) are limited. A total of 6,430 healthy individuals from nine laboratories in Croatia, Hungary, Lithuania, Poland, and Slovakia, included in chromosomal aberration surveys performed during 1978-2002, were followed up for cancer incidence or mortality for an average of 8.5 years; 200 cancer cases were observed. Compared with that for the low-tertile level of chromosomal aberrations, the relative risks of cancer for the medium and high tertiles were 1.78 (95% confidence interval: 1.19, 2.67) and 1.81 (95% confidence interval: 1.20, 2.73), respectively. The relative risk for chromosome-type aberrations above versus below the median was 1.50 (95% confidence interval: 1.12, 2.01), while that for chromatid-type aberrations was 0.97 (95% confidence interval: 0.72, 1.31). The analyses of risk of specific cancers were limited by small numbers, but the association was stronger for stomach cancer. This study confirms the previously reported association between level of chromosomal aberrations and cancer risk and provides novel information on the type of aberrations more strongly predictive of cancer risk and on the types of cancer more strongly predicted by chromosomal aberrations.

Original languageEnglish
Pages (from-to)36-43
Number of pages8
JournalAmerican Journal of Epidemiology
Volume165
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Chromosome Aberrations
Cohort Studies
Neoplasms
Confidence Intervals
Chromatids
Lithuania
Slovakia
Croatia
Hungary
Poland
Stomach Neoplasms
Chromosomes
Lymphocytes
Mortality
Incidence

Keywords

  • Chromosome aberrations
  • Cohort studies
  • Cytogenetics
  • Europe
  • Neoplasms
  • Risk

ASJC Scopus subject areas

  • Epidemiology

Cite this

Boffetta, P., Van Der Hel, O., Norppa, H., Fabianova, E., Fucic, A., Gundy, S., ... Bonassi, S. (2007). Chromosomal aberrations and cancer risk: Results of a cohort study from Central Europe. American Journal of Epidemiology, 165(1), 36-43. https://doi.org/10.1093/aje/kwj367

Chromosomal aberrations and cancer risk : Results of a cohort study from Central Europe. / Boffetta, Paolo; Van Der Hel, Olga; Norppa, Hannu; Fabianova, Eleonora; Fucic, Aleksandra; Gundy, S.; Lazutka, Juozas; Cebulska-Wasilewska, Antonina; Puskailerova, Daniela; Znaor, Ariana; Kelecsenyi, Zsolt; Kurtinaitis, Juozas; Rachtan, Jadwiga; Forni, Alessandra; Vermeulen, Roel; Bonassi, Stefano.

In: American Journal of Epidemiology, Vol. 165, No. 1, 01.2007, p. 36-43.

Research output: Contribution to journalArticle

Boffetta, P, Van Der Hel, O, Norppa, H, Fabianova, E, Fucic, A, Gundy, S, Lazutka, J, Cebulska-Wasilewska, A, Puskailerova, D, Znaor, A, Kelecsenyi, Z, Kurtinaitis, J, Rachtan, J, Forni, A, Vermeulen, R & Bonassi, S 2007, 'Chromosomal aberrations and cancer risk: Results of a cohort study from Central Europe', American Journal of Epidemiology, vol. 165, no. 1, pp. 36-43. https://doi.org/10.1093/aje/kwj367
Boffetta, Paolo ; Van Der Hel, Olga ; Norppa, Hannu ; Fabianova, Eleonora ; Fucic, Aleksandra ; Gundy, S. ; Lazutka, Juozas ; Cebulska-Wasilewska, Antonina ; Puskailerova, Daniela ; Znaor, Ariana ; Kelecsenyi, Zsolt ; Kurtinaitis, Juozas ; Rachtan, Jadwiga ; Forni, Alessandra ; Vermeulen, Roel ; Bonassi, Stefano. / Chromosomal aberrations and cancer risk : Results of a cohort study from Central Europe. In: American Journal of Epidemiology. 2007 ; Vol. 165, No. 1. pp. 36-43.
@article{0f6073b26129411394fb622649e1d182,
title = "Chromosomal aberrations and cancer risk: Results of a cohort study from Central Europe",
abstract = "A high level of chromosomal aberrations in peripheral blood lymphocytes may be an early marker of cancer risk, but data on risk of specific cancers and types of chromosomal aberrations (chromosome type and chromatid type) are limited. A total of 6,430 healthy individuals from nine laboratories in Croatia, Hungary, Lithuania, Poland, and Slovakia, included in chromosomal aberration surveys performed during 1978-2002, were followed up for cancer incidence or mortality for an average of 8.5 years; 200 cancer cases were observed. Compared with that for the low-tertile level of chromosomal aberrations, the relative risks of cancer for the medium and high tertiles were 1.78 (95{\%} confidence interval: 1.19, 2.67) and 1.81 (95{\%} confidence interval: 1.20, 2.73), respectively. The relative risk for chromosome-type aberrations above versus below the median was 1.50 (95{\%} confidence interval: 1.12, 2.01), while that for chromatid-type aberrations was 0.97 (95{\%} confidence interval: 0.72, 1.31). The analyses of risk of specific cancers were limited by small numbers, but the association was stronger for stomach cancer. This study confirms the previously reported association between level of chromosomal aberrations and cancer risk and provides novel information on the type of aberrations more strongly predictive of cancer risk and on the types of cancer more strongly predicted by chromosomal aberrations.",
keywords = "Chromosome aberrations, Cohort studies, Cytogenetics, Europe, Neoplasms, Risk",
author = "Paolo Boffetta and {Van Der Hel}, Olga and Hannu Norppa and Eleonora Fabianova and Aleksandra Fucic and S. Gundy and Juozas Lazutka and Antonina Cebulska-Wasilewska and Daniela Puskailerova and Ariana Znaor and Zsolt Kelecsenyi and Juozas Kurtinaitis and Jadwiga Rachtan and Alessandra Forni and Roel Vermeulen and Stefano Bonassi",
year = "2007",
month = "1",
doi = "10.1093/aje/kwj367",
language = "English",
volume = "165",
pages = "36--43",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Chromosomal aberrations and cancer risk

T2 - Results of a cohort study from Central Europe

AU - Boffetta, Paolo

AU - Van Der Hel, Olga

AU - Norppa, Hannu

AU - Fabianova, Eleonora

AU - Fucic, Aleksandra

AU - Gundy, S.

AU - Lazutka, Juozas

AU - Cebulska-Wasilewska, Antonina

AU - Puskailerova, Daniela

AU - Znaor, Ariana

AU - Kelecsenyi, Zsolt

AU - Kurtinaitis, Juozas

AU - Rachtan, Jadwiga

AU - Forni, Alessandra

AU - Vermeulen, Roel

AU - Bonassi, Stefano

PY - 2007/1

Y1 - 2007/1

N2 - A high level of chromosomal aberrations in peripheral blood lymphocytes may be an early marker of cancer risk, but data on risk of specific cancers and types of chromosomal aberrations (chromosome type and chromatid type) are limited. A total of 6,430 healthy individuals from nine laboratories in Croatia, Hungary, Lithuania, Poland, and Slovakia, included in chromosomal aberration surveys performed during 1978-2002, were followed up for cancer incidence or mortality for an average of 8.5 years; 200 cancer cases were observed. Compared with that for the low-tertile level of chromosomal aberrations, the relative risks of cancer for the medium and high tertiles were 1.78 (95% confidence interval: 1.19, 2.67) and 1.81 (95% confidence interval: 1.20, 2.73), respectively. The relative risk for chromosome-type aberrations above versus below the median was 1.50 (95% confidence interval: 1.12, 2.01), while that for chromatid-type aberrations was 0.97 (95% confidence interval: 0.72, 1.31). The analyses of risk of specific cancers were limited by small numbers, but the association was stronger for stomach cancer. This study confirms the previously reported association between level of chromosomal aberrations and cancer risk and provides novel information on the type of aberrations more strongly predictive of cancer risk and on the types of cancer more strongly predicted by chromosomal aberrations.

AB - A high level of chromosomal aberrations in peripheral blood lymphocytes may be an early marker of cancer risk, but data on risk of specific cancers and types of chromosomal aberrations (chromosome type and chromatid type) are limited. A total of 6,430 healthy individuals from nine laboratories in Croatia, Hungary, Lithuania, Poland, and Slovakia, included in chromosomal aberration surveys performed during 1978-2002, were followed up for cancer incidence or mortality for an average of 8.5 years; 200 cancer cases were observed. Compared with that for the low-tertile level of chromosomal aberrations, the relative risks of cancer for the medium and high tertiles were 1.78 (95% confidence interval: 1.19, 2.67) and 1.81 (95% confidence interval: 1.20, 2.73), respectively. The relative risk for chromosome-type aberrations above versus below the median was 1.50 (95% confidence interval: 1.12, 2.01), while that for chromatid-type aberrations was 0.97 (95% confidence interval: 0.72, 1.31). The analyses of risk of specific cancers were limited by small numbers, but the association was stronger for stomach cancer. This study confirms the previously reported association between level of chromosomal aberrations and cancer risk and provides novel information on the type of aberrations more strongly predictive of cancer risk and on the types of cancer more strongly predicted by chromosomal aberrations.

KW - Chromosome aberrations

KW - Cohort studies

KW - Cytogenetics

KW - Europe

KW - Neoplasms

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=33845894448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845894448&partnerID=8YFLogxK

U2 - 10.1093/aje/kwj367

DO - 10.1093/aje/kwj367

M3 - Article

C2 - 17071846

AN - SCOPUS:33845894448

VL - 165

SP - 36

EP - 43

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 1

ER -